Weight loss achieved through GLP-1 therapy contributes substantially to improved energy perception
These injections are designed to mimic the actions of the naturally occurring GLP-1 hormone, which plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite
Song Z, Levin BE, McArdle JJ, Bakhos N, Routh VH
More serious but less common adverse effects include acute pancreatitis (seek urgent medical attention for severe, persistent abdominal pain), gallbladder disease, and risk of dehydration or acute kidney injury from prolonged vomiting Hypoglycaemia risk : When combined with insulin or sulfonylureas, GLP-1 receptor agonists increase the risk of hypoglycaemia [1] Long-term safety : The extended safety profile in older populations and those with established dementia requires further investigation Patients should report suspected side effects via the MHRA Yellow Card Scheme and discuss both the established benefits for metabolic health and the investigational nature of any cognitive effects with their healthcare provider
GIPR antagonist, 300 nM
For example, if you reduce someones BMI by just one unit (like going from 34 to 33), it doesnt seem like a huge change, but you see an average cost savings of $700 per year on medical spend for someone living with diabetes by reducing that weight